148 related articles for article (PubMed ID: 18214695)
1. C-reactive protein and colorectal adenoma in the CLUE II cohort.
Tsilidis KK; Erlinger TP; Rifai N; Hoffman S; Hoffman-Bolton J; Helzlsouer KJ; Platz EA
Cancer Causes Control; 2008 Aug; 19(6):559-67. PubMed ID: 18214695
[TBL] [Abstract][Full Text] [Related]
2. Plasma C-reactive protein and risk of colorectal cancer in a nested case-control study: Japan Public Health Center-based prospective study.
Otani T; Iwasaki M; Sasazuki S; Inoue M; Tsugane S;
Cancer Epidemiol Biomarkers Prev; 2006 Apr; 15(4):690-5. PubMed ID: 16614110
[TBL] [Abstract][Full Text] [Related]
3. C-reactive protein concentrations and subsequent ovarian cancer risk.
McSorley MA; Alberg AJ; Allen DS; Allen NE; Brinton LA; Dorgan JF; Pollak M; Tao Y; Helzlsouer KJ
Obstet Gynecol; 2007 Apr; 109(4):933-41. PubMed ID: 17400857
[TBL] [Abstract][Full Text] [Related]
4. No association between pre-diagnostic plasma C-reactive protein concentration and subsequent prostate cancer.
Platz EA; De Marzo AM; Erlinger TP; Rifai N; Visvanathan K; Hoffman SC; Helzlsouer KJ
Prostate; 2004 Jun; 59(4):393-400. PubMed ID: 15065087
[TBL] [Abstract][Full Text] [Related]
5. A prospective study of serum C-reactive protein and colorectal cancer risk in men.
Gunter MJ; Stolzenberg-Solomon R; Cross AJ; Leitzmann MF; Weinstein S; Wood RJ; Virtamo J; Taylor PR; Albanes D; Sinha R
Cancer Res; 2006 Feb; 66(4):2483-7. PubMed ID: 16489056
[TBL] [Abstract][Full Text] [Related]
6. Selenium and colorectal adenoma: results of a pooled analysis.
Jacobs ET; Jiang R; Alberts DS; Greenberg ER; Gunter EW; Karagas MR; Lanza E; Ratnasinghe L; Reid ME; Schatzkin A; Smith-Warner SA; Wallace K; Martínez ME
J Natl Cancer Inst; 2004 Nov; 96(22):1669-75. PubMed ID: 15547179
[TBL] [Abstract][Full Text] [Related]
7. Insulin resistance, apoptosis, and colorectal adenoma risk.
Keku TO; Lund PK; Galanko J; Simmons JG; Woosley JT; Sandler RS
Cancer Epidemiol Biomarkers Prev; 2005 Sep; 14(9):2076-81. PubMed ID: 16172212
[TBL] [Abstract][Full Text] [Related]
8. Inflammation-related gene polymorphisms and colorectal adenoma.
Gunter MJ; Canzian F; Landi S; Chanock SJ; Sinha R; Rothman N
Cancer Epidemiol Biomarkers Prev; 2006 Jun; 15(6):1126-31. PubMed ID: 16775170
[TBL] [Abstract][Full Text] [Related]
9. Serum triglycerides and colorectal adenoma in a case-control study among cancer screening examinees (Japan).
Otani T; Iwasaki M; Ikeda S; Kozu T; Saito H; Mutoh M; Wakabayashi K; Tsugane S
Cancer Causes Control; 2006 Dec; 17(10):1245-52. PubMed ID: 17111255
[TBL] [Abstract][Full Text] [Related]
10. Plasma insulin-like growth factor I is inversely associated with colorectal adenoma recurrence: a novel hypothesis.
Jacobs ET; Martínez ME; Alberts DS; Ashbeck EL; Gapstur SM; Lance P; Thompson PA
Cancer Epidemiol Biomarkers Prev; 2008 Feb; 17(2):300-5. PubMed ID: 18250342
[TBL] [Abstract][Full Text] [Related]
11. Association of obesity, serum glucose and lipids with the risk of advanced colorectal adenoma and cancer: a case-control study in Korea.
Chung YW; Han DS; Park YK; Son BK; Paik CH; Lee HL; Jeon YC; Sohn JH
Dig Liver Dis; 2006 Sep; 38(9):668-72. PubMed ID: 16790371
[TBL] [Abstract][Full Text] [Related]
12. Prediagnostic serum selenium concentration and the risk of recurrent colorectal adenoma: a nested case-control study.
Wallace K; Byers T; Morris JS; Cole BF; Greenberg ER; Baron JA; Gudino A; Spate V; Karagas MR
Cancer Epidemiol Biomarkers Prev; 2003 May; 12(5):464-7. PubMed ID: 12750244
[TBL] [Abstract][Full Text] [Related]
13. High serum selenium and reduced risk of advanced colorectal adenoma in a colorectal cancer early detection program.
Peters U; Chatterjee N; Church TR; Mayo C; Sturup S; Foster CB; Schatzkin A; Hayes RB
Cancer Epidemiol Biomarkers Prev; 2006 Feb; 15(2):315-20. PubMed ID: 16492922
[TBL] [Abstract][Full Text] [Related]
14. Is C-reactive protein a prognostic factor of colorectal cancer?
Shiu YC; Lin JK; Huang CJ; Jiang JK; Wang LW; Huang HC; Yang SH
Dis Colon Rectum; 2008 Apr; 51(4):443-9. PubMed ID: 18172726
[TBL] [Abstract][Full Text] [Related]
15. Patients with sporadic duodenal adenoma are a high-risk group for advanced colorectal neoplasia: results of a case-control study.
Pequin P; Manfredi S; Quentin V; Heresbach D; Boyer J; Siproudhis L; Bretagne JF
Aliment Pharmacol Ther; 2007 Jul; 26(2):277-82. PubMed ID: 17593073
[TBL] [Abstract][Full Text] [Related]
16. Plasma enterolignans are associated with lower colorectal adenoma risk.
Kuijsten A; Arts IC; Hollman PC; van't Veer P; Kampman E
Cancer Epidemiol Biomarkers Prev; 2006 Jun; 15(6):1132-6. PubMed ID: 16775171
[TBL] [Abstract][Full Text] [Related]
17. Insulin therapy and colorectal adenoma risk among patients with Type 2 diabetes mellitus: a case-control study in Korea.
Chung YW; Han DS; Park KH; Eun CS; Yoo KS; Park CK
Dis Colon Rectum; 2008 May; 51(5):593-7. PubMed ID: 18219529
[TBL] [Abstract][Full Text] [Related]
18. Erythrocyte membrane phospholipid fatty acid concentrations and risk of colorectal adenomas: a case-control nested in the French E3N-EPIC cohort study.
Cottet V; Collin M; Gross AS; Boutron-Ruault MC; Morois S; Clavel-Chapelon F; Chajès V
Cancer Epidemiol Biomarkers Prev; 2013 Aug; 22(8):1417-27. PubMed ID: 23704475
[TBL] [Abstract][Full Text] [Related]
19. Elevation of C-reactive protein level is associated with synchronous and advanced colorectal neoplasm in men.
Chiu HM; Lin JT; Chen TH; Lee YC; Chiu YH; Liang JT; Shun CT; Wu MS
Am J Gastroenterol; 2008 Sep; 103(9):2317-25. PubMed ID: 18844617
[TBL] [Abstract][Full Text] [Related]
20. Plasma enterolignan concentrations and colorectal cancer risk in a nested case-control study.
Kuijsten A; Hollman PC; Boshuizen HC; Buijsman MN; van 't Veer P; Kok FJ; Arts IC; Bueno-de-Mesquita HB
Am J Epidemiol; 2008 Mar; 167(6):734-42. PubMed ID: 18192676
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
